302
Views
7
CrossRef citations to date
0
Altmetric
Oral Rosuvastatin versus Progesterone and Bevacizumab in endometriotic implants in rats

Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats

, , , , , , , , & show all
Pages 923-927 | Received 19 Jan 2017, Accepted 13 Apr 2017, Published online: 28 Apr 2017

References

  • Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927;3:93–110
  • Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997;24:235–8
  • Harlev A, Gupta S, Agarwal A. Targeting oxidative stress to treat endometriosis. Expert Opin Ther Targets 2015;19:1447–64
  • Murphy AA, Santanam N, Parthasarathy S. Endometriosis: a disease of oxidative stress? Semin Reprod Endocrinol 1998;16:263–73
  • Donnez J, Binda MM, Donnez O, Dolmans MM. Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis. Fertil Steril 2016;106:1011–7
  • Vitagliano A, Noventa M, Quaranta M, Gizzo S. Statins as targeted “magical pills” for the conservative treatment of endometriosis: may potential adverse effects on female fertility represent the “dark side of the same coin”? A systematic review of literature? Reprod Sci 2016;23:415–28
  • Gibran L, Maranhão RC, Abrão MS, et al. Could statins constitute a novel treatment for endometriosis? Systematic review of the literature. Eur J Obstet Gynecol Reprod Biol 2014;179:153–8
  • Vercellini P, Buggio L, Berlanda N, et al Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril 2016;106:1552–71.e2
  • Gezer A, Oral E. Progestin therapy in endometriosis. Womens Health (Lond) 2015;11:643–52
  • Soysal D, Kızıldağ S, Saatlı B, et al. A novel angiogenesis inhibitor bevacizumab induces apoptosis in the rat endometriosis model. Balkan J Med Genet 2015;17:73–80
  • Ozer H, Boztosun A, Açmaz G, et al. The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model. Reprod Sci 2013;20:26–32
  • Keenan JA, Williams-Boyce PK, Massey PJ, et al. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril 1999; 72:135–41
  • Zhang J, Zhu Y, Zhou X, et al. Evaluation of biodegradable microspheres containing nomegestrol acetate in a rat model of endometriosis. Eur J Pharm Sci 2014;65:15–20
  • Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 1985;44:684–94
  • Sample WF, Lippe BM, Gyepes MT. Gray-scale ultrasonography of the normal female pelvis. Radiology 1977;125:477–83
  • Charan J, Kantharia ND. How to calculate sample size in animal studies? J Pharmacol Pharmacother 2013;4:303–6
  • Dlugi AM, Miller JD, Knittle J. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group. Fertil Steril 1990;54:419–27
  • Turkyilmaz E, Yildirim M, Cendek BD, et al. Evaluation of oxidative stress markers and intra-extracellular antioxidant activities in patients with endometriosis. Eur J Obstet Gynecol Reprod Biol 2016;199:164–8
  • Jiang L, Yan Y, Liu Z, Wang Y. Inflammation and endometriosis. Front Biosci (Landmark Ed) 2016;21:941–8
  • Sikora J, Smycz-Kubańska M, Mielczarek-Palacz A, Kondera-Anasz Z. Abnormal peritoneal regulation of chemokine activation-The role of IL-8 in pathogenesis of endometriosis. Am J Reprod Immunol 2017. [Epub ahead of print]. doi: 10.1111/aji.12622
  • Groothuis PG, Nap AW, Winterhager E, Grümmer R. Vascular development in endometriosis. Angiogenesis 2005;8:147–56
  • Donnez J, Smoes P, Gillerot S, et al. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998;13:1686–90
  • Hull ML, Charnock-Jones DS, Chan CL, et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 2003;88:2889–99
  • Ricci AG, Olivares CN, Bilotas MA, et al. Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis. Reprod Sci 2011;18:614–22
  • Murakami M, Iwai S, Hiratsuka S, et al. Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages. Blood 2006;108:1849–56
  • Beddy D, Watson RW, Fitzpatrick JM, O’Connell PR. Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn’s disease. Br J Surg 2004;91:72–7
  • Nakagomi A, Shibui T, Kohashi K, et al. Differential effects of atorvastation and pitavastatin on inflammation, insulin resistance, and the carotid intima-media thickness in patients with dyslipidemia. J Atheroscler Thromb 2015;22:1158–71
  • Cheng G, Xiang H, Yang G, et al. Bevacizumab inhibits angiogenesis and inflammation in rat filtration surgery model. Cell Biochem Biophys 2015;73:71–7
  • Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 2005;4:977–87
  • Zhou Q, Liao JK. Pleiotropic effects of statins - basic research and clinical perspectives. Circ J 2010;74:818–26
  • Ghaisas MM, Dandawate PR, Zawar SA, et al. Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models. Inflammopharmacology 2010;18:169–77
  • Humar R, Kiefer FN, Berns H, et al. Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J 2002;16:771–80
  • Mancini D, Pinney S, Burkhoff D, et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003;108:48–53
  • Rutishauser J. The role of statins in clinical medicine-LDL-cholesterol lowering and beyond. Swiss Med Wkly 2006;136:41–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.